Helus Pharma Inc. (HELP) vs OmniAb, Inc. (OABI)
A side-by-side comparison of Helus Pharma Inc. and OmniAb, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
HELP
Helus Pharma Inc.
$10.99HealthcareDelayed quote: Oct 6, 2026, 12:15 PM EDT
OABI
OmniAb, Inc.
$4.52HealthcareDelayed quote: Oct 6, 2026, 12:15 PM EDT
Total return — HELP vs OABI
growth of $100 · dividends reinvested · last 1yHELP +93.2% (+93.2%/yr)OABI +152.3% (+152.3%/yr)OABI compounded faster over this window
HELP OABI
HELP vs OABI: by the numbers
- •HELP is the larger company ($681M vs $655M market cap).
- •HELP is profitable (329.09% net margin) while OABI runs a net loss (-115.18%).
Metrics side by side
Valuation
| Metric | HELP | OABI |
|---|---|---|
| P/S ratio | N/A | 17.03 |
| P/B ratio | 2.82 | 2.51 |
Profitability
| Metric | HELP | OABI |
|---|---|---|
| Gross margin | 100.27% | -18.17% |
| Operating margin | 317.06% | -383.15% |
| Net margin | 329.09% | -115.18% |
| ROE | -75.79% | -17.01% |
| ROIC | -73.27% | -17.48% |
Growth (annualized)
| Metric | HELP | OABI |
|---|---|---|
| Revenue CAGR (5Y) | N/A | -4.31% |
| Total return CAGR (5Y) | N/A | -13.17% |
Frequently asked
- Is HELP or OABI more profitable?
- HELP runs the higher net margin — HELP at 329.09% versus OABI at -115.18%.
Go deeper
Dig into the metrics
Helus Pharma ROEOmniAb ROEHelus Pharma operating marginOmniAb operating marginHelus Pharma revenue growthOmniAb revenue growthHelus Pharma free cash flowOmniAb free cash flow
Helus Pharma & OmniAb appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.